本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Madrigal Pharmaceuticals, Inc.

534.40
+5.311.00%
成交量:15.33萬
成交額:8,158.44萬
市值:123.21億
市盈率:-37.59
高:539.29
開:534.69
低:526.26
收:529.09
52周最高:615.00
52周最低:393.61
股本:2,305.55萬
流通股本:1,372.50萬
量比:0.68
換手率:1.12%
股息:- -
股息率:- -
每股收益(TTM):-14.2164
每股收益(LYR):-12.8501
淨資產收益率:-53.31%
總資產收益率:-17.84%
市淨率:23.53
市盈率(LYR):-41.59

資料載入中...

2023/06/20

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/03

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

重要事件披露

8-K - Current report
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/10

重要事件披露

8-K - Current report
2022/12/23

重要事件披露

8-K - Current report
2022/12/19

重要事件披露

8-K - Current report
2022/11/03

重要事件披露

8-K - Current report
2022/11/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]